Nitric oxide and hydroperoxide affect islet hormone release and Ca2+ efflux

被引:21
作者
Åkesson, B [1 ]
Lundquist, I [1 ]
机构
[1] Univ Lund, Dept Pharmacol, S-22362 Lund, Sweden
关键词
insulin and glucagon secretion; glucose; Ca-45(2+)-efflux; cAMP activation; hydroxylamine; tert-butylhydroperoxide;
D O I
10.1385/ENDO:11:1:99
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have investigated the influence of the intracellular free radical donors hydroxylamine (giving nitric oxide [NO]) and tert-butylhydroperoxide (giving hydroperoxide ["H2O2"]) on glucose- and cyclic adenosine monophosphate (cAMP)-induced transduction signaling in islet hormone release. Both donors dose dependently inhibited glucose-stimulated insulin release and induced modest (hydroxylamine) or profound (tert-butylhydroperoxide) suppression of Ca-45(2+)-efflux from perifused islets. By contrast, both donors stimulated glucagon release. Similar effects on hormone release were displayed after K+-depolarization. Insulin and glucagon release stimulated by activation of the cAMP system through isobutylmethylxanthine (IBMX) at basal glucose was modestly potentiated by low concentrations of both donors. These effects were still observed, although less pronounced, in K+-depolarized islets. In vitro as well as in vivo, the NO-synthase inhibitor N-G-nitro-L-arginine methyl ester inhibited IBMX-induced glucagon release, but did not affect insulin release. The results suggest that NO and hydroperoxide inhibit glucose-stimulated insulin release by perturbing Ca2+ fluxes and probably acting through S-nitrosylation (NO) or oxidation (hydroperoxide) of thiol groups critical to the secretory process. These effects are largely independent of depolarization events. By contrast, both NO and hydroperoxide can potentiate cAMP-stimulated hormone release presumably at a distal site in the stimulus-secretion coupling.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 45 条
  • [1] GLUCAGON IMMUNOREACTIVITY IN PLASMA FROM NORMAL AND DYSTROPHIC MICE
    AHREN, B
    LUNDQUIST, I
    [J]. DIABETOLOGIA, 1982, 22 (04) : 258 - 263
  • [2] Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets
    Åkesson, B
    Lundquist, I
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1999, 515 (02): : 463 - 473
  • [3] Evidence for nitric oxide mediated effects on islet hormone secretory phospholipase C signal transduction mechanisms
    Åkesson, B
    Lundquist, I
    [J]. BIOSCIENCE REPORTS, 1998, 18 (04) : 199 - 213
  • [4] Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice
    Akesson, B
    Mosen, H
    Panagiotidis, G
    Lundquist, I
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (04) : 758 - 764
  • [5] Akesson B, 1996, DIABETES RES, V31, P91
  • [6] THIOLS AND PANCREATIC BETA-CELL FUNCTION - A REVIEW
    AMMON, HPT
    MARK, M
    [J]. CELL BIOCHEMISTRY AND FUNCTION, 1985, 3 (03) : 157 - 171
  • [7] EFFECT OF METHYLENE-BLUE AND THIOL OXIDANTS ON PANCREATIC-ISLET GSH-GSSG RATIOS AND TOLBUTAMIDE MEDIATED INSULIN RELEASE INVITRO
    AMMON, HPT
    AKHTAR, MS
    GRIMM, A
    NIKLAS, H
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1979, 307 (01) : 91 - 96
  • [8] AMMON HPT, 1977, MOL PHARMACOL, V13, P598
  • [9] Hydroxylamine, a nitric oxide donor, inhibits insulin release and activates K-ATP(+) channels
    Antoine, MH
    Ouedraogo, R
    Sergooris, J
    Hermann, M
    Herchuelz, A
    Lebrun, P
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (03) : 229 - 235
  • [10] NITRIC-OXIDE MEDIATES IL-1-BETA-INDUCED ISLET DYSFUNCTION AND DESTRUCTION - PREVENTION BY DEXAMETHASONE
    CORBETT, JA
    WANG, JL
    MISKO, TP
    ZHAO, WG
    HICKEY, WF
    MCDANIEL, ML
    [J]. AUTOIMMUNITY, 1993, 15 (02) : 145 - 153